Australia's largest stock trading and investment forum Australia's #1 stock forum

CHM

Click for more information

0.00%

1.4¢ chimeric therapeutics limited

that’s exactly it, perfectly said. RAD in same position too

First 661 Last

Share
Profile

Follow
lukeandrew1

2,177 Posts.

224

29/03/24

18:57

Post #: 73120027
Share

Originally posted by bingboi: ↑

Most likely due to the micro and small cap biotech environment. Companies not producing Cash have been punished indiscriminately due to having to raise money when interest rates are higher so the cost of cash has been higher, especially in biotech who are constantly raising money to fund clinical trials. While results so far have been promising, CHM hasn't been immune to this and have had a couple cap raises. This is also unlikely to change going forward until CHM has a product to sell, it I assume it will have to keep funding with raises. With expectations around falling interest rates later this year or early next year, we could see a re-rate across the sector as cash becomes cheaper to access which would hopefully lift CHM as well. Plus, positive results here should send this upwards too.

Expand

that’s exactly it, perfectly said. RAD in same position too

CHM Price at posting: 3.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

LTM

Rio Tinto confirms it's lobbed a takeover offer at Arcadium Lithium

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 227 more messages in this thread...

First 661 Last

Add CHM (ASX) to my watchlist